Sahar Alothman

Dr. Sahar J. Alothman, Ph.D. is an accomplished medical and scientific director specializing in oncology and scientific education. At AstraZeneca, she leads global initiatives to advance cancer therapeutics and optimize medical training. Dr. Alothman has pioneered the development of innovative training approaches, integrating AI-driven learning and digital health solutions to elevate scientific engagement and retention across diverse medical teams. With an interdisciplinary background in tumor biology and a proven record of spearheading clinical trials, educational programs, and evidence generation, she is dedicated to enhancing patient care through technology and collaboration. Dr. Alothman’s work exemplifies the transformative impact of AI in medical learning and professional development, positioning her as a thought leader in leveraging artificial intelligence for healthcare innovation.